Boao International Medical Center
| Tiongkok | Turki | Austria | |
| Terapi medikamentosa untuk Lupus Eritematosus Sistemik | ≈ $1,800 | ≈ $900 | ≈ $2,400 |
| Terapi Intravena Kurkumin | ≈ $600 | ≈ $900 | ≈ $900 |
| Plasmapheresis DFPP | ≈ $450 | ≈ $1,900 | ≈ $1,400 |
| Plasmaferesis | ≈ $2,200 | dari $3,200 | ≈ $2,000 |
| Pertukaran plasma | ≈ $2,400 | ≈ $3,900 | ≈ $3,800 |
Bookimed tidak menambah biaya tambahan dalam harga perawatan Reumatologi. Tarif berasal dari daftar harga resmi klinik. Anda membayar langsung di klinik saat tiba di negara tujuan untuk perawatan Anda.
Bookimed berkomitmen pada keselamatan Anda. Kami hanya bekerja dengan institusi medis yang menjaga standar internasional tinggi dalam perawatan Reumatologi dan memiliki izin yang dibutuhkan untuk melayani pasien internasional di seluruh dunia.
Bookimed menawarkan bantuan ahli gratis. Koordinator medis pribadi mendukung Anda sebelum, selama, dan setelah perawatan, menyelesaikan semua masalah Anda. Anda tidak pernah sendirian dalam perjalanan perawatan Reumatologi Anda.
Dr. Lin Shudian, MD, is Chief Physician and Director of Rheumatology and Immunology. He focuses on autoimmune diseases, especially inflammatory myopathies. He earned his MD in 2007 from Xiangya Hospital, Central South University. He completed advanced rheumatology training at Peking Union Medical College Hospital in 2015. He is Chairman of the Hainan Provincial Rheumatology Association. He is a committee member of the Rheumatology Branches of the Chinese Medical Association and the Chinese Medical Doctor Association. He is Deputy Director of the Hainan Provincial Medical Doctor Association Rheumatology Branch. He is an NSFC reviewer and serves on the editorial board of Hainan Medical Journal.
He has led three projects funded by the NSFC or Hainan Province. He has published more than 10 papers, including four indexed in SCI. He contributed to the translation of Kelley and Firestein’s Textbook of Rheumatology (8th–10th editions). He also helped compile Advanced Clinical Rheumatology, the 2020 China SLE Report, Comprehensive Rheumatology, and Liver-Related Rheumatic Diseases.